Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.carbpol.2025.123941 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Doxorubicin delivered by redox-responsive Hyaluronic Acid-Ibuprofen prodrug micelles for treatment of metastatic breast cancer" [Carbohydrate Polymers 245 (2020) 116527].
Carbohydr Polym
October 2025
School of Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address:
Corrigendum: Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer.
Front Bioeng Biotechnol
June 2025
Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China.
[This corrects the article DOI: 10.3389/fbioe.2023.
View Article and Find Full Text PDFCorrigendum: Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats.
Front Mol Biosci
May 2025
Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.
[This corrects the article DOI: 10.3389/fmolb.2024.
View Article and Find Full Text PDFCorrigendum: Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response.
Front Immunol
April 2025
Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrigendum to "Effect of cell imprinting on viability and drug susceptibility of breast cancer cells to doxorubicin" [Acta Biomaterialia, 2020, 113, 119-129].
Acta Biomater
May 2025
Departments of Bioengineering, Chemical and Biomolecular Engineering and Radiological Sciences, Center for Minimally Invasive Therapeutics, California NanoSystems Institute, University of California - Los Angeles, Los Angeles, CA, USA; Terasaki Institute for Biomedical Innovation, Los Angeles, CA, U